Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome

Christopher L. Hunter, Ole Isacson, Matthew Nelson, Heather Bimonte-Nelson, Hyemyung Seo, Ling Lin, Kerstin Ford, Mark S. Kindy, Ann Charlotte Granholm

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Individuals with Down's syndrome (DS) develop the pathological hallmarks of Alzheimer's (AD) disease at an early age, subsequently followed by memory decline and dementia. We have utilized an animal model for DS, mice with segmental trisomy of chromosome 16 (Ts65Dn), to study biological events linked to memory loss. Previous studies demonstrated a cognitive decline and loss of cholinergic markers after 6-8 months of age. In the current study, we found increased levels of amyloid precursor protein (APP) in the striatum by 6-8 months of age, and in the hippocampus and parietal cortex by 13-16 months of age in Ts65Dn but not in normosomic mice. Additionally, Ts65Dn mice exhibited alterations in nerve growth factor (NGF) levels in the basal forebrain and hippocampus. Ts65Dn mice demonstrated a significant decline in NGF levels in the basal forebrain with age, as well as a reduction in hippocampal NGF by 13-16 months of age. These findings demonstrate that elevated APP and decreased NGF levels in limbic areas correlate with the progressive memory decline and cholinergic degeneration seen in middle-aged trisomic mice.

Original languageEnglish (US)
Pages (from-to)437-445
Number of pages9
JournalNeuroscience Research
Volume45
Issue number4
DOIs
StatePublished - Apr 1 2003
Externally publishedYes

Fingerprint

Amyloid beta-Protein Precursor
Nerve Growth Factor
Down Syndrome
Cholinergic Agents
Hippocampus
Parietal Lobe
Memory Disorders
Dementia
Alzheimer Disease
Animal Models
Basal Forebrain

Keywords

  • Alzheimer's disease
  • Amyloid precursor protein
  • Down's Syndrome
  • Hippocampus
  • Nerve growth factor
  • Neurodegeneration
  • Ts65Dn

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome. / Hunter, Christopher L.; Isacson, Ole; Nelson, Matthew; Bimonte-Nelson, Heather; Seo, Hyemyung; Lin, Ling; Ford, Kerstin; Kindy, Mark S.; Granholm, Ann Charlotte.

In: Neuroscience Research, Vol. 45, No. 4, 01.04.2003, p. 437-445.

Research output: Contribution to journalArticle

Hunter, Christopher L. ; Isacson, Ole ; Nelson, Matthew ; Bimonte-Nelson, Heather ; Seo, Hyemyung ; Lin, Ling ; Ford, Kerstin ; Kindy, Mark S. ; Granholm, Ann Charlotte. / Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome. In: Neuroscience Research. 2003 ; Vol. 45, No. 4. pp. 437-445.
@article{84bbb74616d6411ba2d2288755b804bb,
title = "Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome",
abstract = "Individuals with Down's syndrome (DS) develop the pathological hallmarks of Alzheimer's (AD) disease at an early age, subsequently followed by memory decline and dementia. We have utilized an animal model for DS, mice with segmental trisomy of chromosome 16 (Ts65Dn), to study biological events linked to memory loss. Previous studies demonstrated a cognitive decline and loss of cholinergic markers after 6-8 months of age. In the current study, we found increased levels of amyloid precursor protein (APP) in the striatum by 6-8 months of age, and in the hippocampus and parietal cortex by 13-16 months of age in Ts65Dn but not in normosomic mice. Additionally, Ts65Dn mice exhibited alterations in nerve growth factor (NGF) levels in the basal forebrain and hippocampus. Ts65Dn mice demonstrated a significant decline in NGF levels in the basal forebrain with age, as well as a reduction in hippocampal NGF by 13-16 months of age. These findings demonstrate that elevated APP and decreased NGF levels in limbic areas correlate with the progressive memory decline and cholinergic degeneration seen in middle-aged trisomic mice.",
keywords = "Alzheimer's disease, Amyloid precursor protein, Down's Syndrome, Hippocampus, Nerve growth factor, Neurodegeneration, Ts65Dn",
author = "Hunter, {Christopher L.} and Ole Isacson and Matthew Nelson and Heather Bimonte-Nelson and Hyemyung Seo and Ling Lin and Kerstin Ford and Kindy, {Mark S.} and Granholm, {Ann Charlotte}",
year = "2003",
month = "4",
day = "1",
doi = "10.1016/S0168-0102(03)00005-1",
language = "English (US)",
volume = "45",
pages = "437--445",
journal = "Neuroscience Research",
issn = "0168-0102",
publisher = "Elsevier Ireland Ltd",
number = "4",

}

TY - JOUR

T1 - Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome

AU - Hunter, Christopher L.

AU - Isacson, Ole

AU - Nelson, Matthew

AU - Bimonte-Nelson, Heather

AU - Seo, Hyemyung

AU - Lin, Ling

AU - Ford, Kerstin

AU - Kindy, Mark S.

AU - Granholm, Ann Charlotte

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Individuals with Down's syndrome (DS) develop the pathological hallmarks of Alzheimer's (AD) disease at an early age, subsequently followed by memory decline and dementia. We have utilized an animal model for DS, mice with segmental trisomy of chromosome 16 (Ts65Dn), to study biological events linked to memory loss. Previous studies demonstrated a cognitive decline and loss of cholinergic markers after 6-8 months of age. In the current study, we found increased levels of amyloid precursor protein (APP) in the striatum by 6-8 months of age, and in the hippocampus and parietal cortex by 13-16 months of age in Ts65Dn but not in normosomic mice. Additionally, Ts65Dn mice exhibited alterations in nerve growth factor (NGF) levels in the basal forebrain and hippocampus. Ts65Dn mice demonstrated a significant decline in NGF levels in the basal forebrain with age, as well as a reduction in hippocampal NGF by 13-16 months of age. These findings demonstrate that elevated APP and decreased NGF levels in limbic areas correlate with the progressive memory decline and cholinergic degeneration seen in middle-aged trisomic mice.

AB - Individuals with Down's syndrome (DS) develop the pathological hallmarks of Alzheimer's (AD) disease at an early age, subsequently followed by memory decline and dementia. We have utilized an animal model for DS, mice with segmental trisomy of chromosome 16 (Ts65Dn), to study biological events linked to memory loss. Previous studies demonstrated a cognitive decline and loss of cholinergic markers after 6-8 months of age. In the current study, we found increased levels of amyloid precursor protein (APP) in the striatum by 6-8 months of age, and in the hippocampus and parietal cortex by 13-16 months of age in Ts65Dn but not in normosomic mice. Additionally, Ts65Dn mice exhibited alterations in nerve growth factor (NGF) levels in the basal forebrain and hippocampus. Ts65Dn mice demonstrated a significant decline in NGF levels in the basal forebrain with age, as well as a reduction in hippocampal NGF by 13-16 months of age. These findings demonstrate that elevated APP and decreased NGF levels in limbic areas correlate with the progressive memory decline and cholinergic degeneration seen in middle-aged trisomic mice.

KW - Alzheimer's disease

KW - Amyloid precursor protein

KW - Down's Syndrome

KW - Hippocampus

KW - Nerve growth factor

KW - Neurodegeneration

KW - Ts65Dn

UR - http://www.scopus.com/inward/record.url?scp=0344405753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344405753&partnerID=8YFLogxK

U2 - 10.1016/S0168-0102(03)00005-1

DO - 10.1016/S0168-0102(03)00005-1

M3 - Article

VL - 45

SP - 437

EP - 445

JO - Neuroscience Research

JF - Neuroscience Research

SN - 0168-0102

IS - 4

ER -